About this trial
The goal of this randomized, double-blind, placebo-controlled study included pregnant women at high risk of GDM at 6-15 weeks of gestation is to investigate whether supplementation with vitamin D (1600 IU per day) or prebiotics (inulin, 10 gram per day) during pregnancy has beneficial effects on controlling blood glucose during pregnancy.
Eligibility criteria
Qualifiers
6-15 weeks of gestation.
Age 18-45 years old.
Permanent resident or resident locally at least one year.
Pre-pregnancy body mass index (BMI) ≥24.0 kg/m2,
Disqualifiers
Multiple pregnancy.
Have received infertility treatment such as in vitro fertilization or intrauterine insemination.
History of diabetes or current diagnosis of diabetes (including type 1 and type 2 diabetes) or abnormal glucose tolerance at recruitment (fasting blood glucose >7.0 mmol/L or HbA1c≥6.5%).
Serious chronic diseases (including cardiovascular and cerebrovascular diseases, cancer, and thyroid dysfunction) or infectious diseases (including hepatitis B, active tuberculosis, acquired immunodeficiency syndrome, and syphilis).
Trial design
Treatments tested in this trial
- Vitamin D3
- Prebiotics
- Prebiotics placebo
- Vitamin D3 placebo